Clinical Implications of C-Maf Expression in Plasma Cells from Patients with Multiple Myeloma

GuoQing Wei,LiJun Wang,HanJin Yang,XiaoYan Han,GaoFeng Zheng,WeiYan Zheng,Jie Sun,JiMin Shi,WenJun Wu,Yi Zhao,DongHua He,Bo Wang,Zhen Cai,JingSong He
DOI: https://doi.org/10.1186/s40164-017-0076-3
2017-01-01
Experimental Hematology and Oncology
Abstract:Multiple myeloma (MM) is a type of hematological malignancy with significant heterogeneity in clinical features and prognosis. Cytogenetic abnormalities are the major factors affecting patient outcomes. Studies have shown that immunohistochemistry (IHC)-based detection of cancer-related genes expression could be alternative indicators for the prognosis of MM.
What problem does this paper attempt to address?